93 related articles for article (PubMed ID: 18407683)
1. Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m.
Levashova Z; Backer M; Backer JM; Blankenberg FG
Bioconjug Chem; 2008 May; 19(5):1049-54. PubMed ID: 18407683
[TBL] [Abstract][Full Text] [Related]
2. In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF.
Blankenberg FG; Backer MV; Levashova Z; Patel V; Backer JM
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):841-8. PubMed ID: 16699765
[TBL] [Abstract][Full Text] [Related]
3. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
4. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
[TBL] [Abstract][Full Text] [Related]
5. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
7. Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF.
Levashova Z; Backer M; Backer JM; Blankenberg FG
J Nucl Med; 2009 Dec; 50(12):2058-63. PubMed ID: 19910439
[TBL] [Abstract][Full Text] [Related]
8. A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
Chan C; Sandhu J; Guha A; Scollard DA; Wang J; Chen P; Bai K; Lee L; Reilly RM
J Nucl Med; 2005 Oct; 46(10):1745-52. PubMed ID: 16204726
[TBL] [Abstract][Full Text] [Related]
9. Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis.
Blankenberg FG; Levashova Z; Goris MG; Hamby CV; Backer MV; Backer JM
J Nucl Med; 2011 Oct; 52(10):1630-7. PubMed ID: 21890879
[TBL] [Abstract][Full Text] [Related]
10. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
11. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag.
Backer MV; Patel V; Jehning BT; Claffey KP; Backer JM
Biomaterials; 2006 Nov; 27(31):5452-8. PubMed ID: 16843524
[TBL] [Abstract][Full Text] [Related]
12. Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition.
Bouziotis P; Fani M; Archimandritis SC; Loundos G; Paravatou M; Bicknell R; Harris AL; Xanthopoulos S; Stratis N; Varvarigou AD
Anticancer Res; 2003; 23(3A):2167-71. PubMed ID: 12894592
[TBL] [Abstract][Full Text] [Related]
13. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1.
Perret GY; Starzec A; Hauet N; Vergote J; Le Pecheur M; Vassy R; Léger G; Verbeke KA; Bormans G; Nicolas P; Verbruggen AM; Moretti JL
Nucl Med Biol; 2004 Jul; 31(5):575-81. PubMed ID: 15219275
[TBL] [Abstract][Full Text] [Related]
16. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
17. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled GX1 Peptide for Tumor Angiogenesis Imaging.
de Oliveira ÉA; Faintuch BL; Seo D; Barbezan AB; Funari A; Targino RC; Moro AM
Appl Biochem Biotechnol; 2018 Aug; 185(4):863-874. PubMed ID: 29362989
[TBL] [Abstract][Full Text] [Related]
19. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
